Efficacy and Safety of Sacubitril/Valsartan in the Treatment of Heart Failure: Protocol for a Systematic Review Incorporating Unpublished Clinical Study Reports

HRB Open Research
doi 10.12688/hrbopenres.12951.1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Faculty of 1000 Ltd

Related search

Sacubitril/Valsartan: Evaluation of Safety and Efficacy as an Antihypertensive Treatment

Drugs in Context
Molecular MedicinePharmacology
2018English

Sacubitril-Valsartan in Heart Failure and Multimorbidity Patients

ESC heart failure
Cardiovascular MedicineCardiology
2018English

Reply: Sacubitril/Valsartan for Chagas' Heart Disease Heart Failure?

ESC heart failure
Cardiovascular MedicineCardiology
2018English

Cost-Effectiveness of Sacubitril/Valsartan in the Treatment of Heart Failure in Colombia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Profile of Sacubitril/Valsartan in the Treatment of Heart Failure: Patient Selection and Perspectives

Vascular Health and Risk Management
2017English

Safety of Initiation of Sacubitril/Valsartan in ICU Patients With Advanced Decompensated Heart Failure

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

The Neprilysin Pathway in Heart Failure: A Review and Guide on the Use of Sacubitril/Valsartan

Heart
Cardiovascular MedicineCardiology
2016English

The Combination of Valsartan and Sacubitril in the Treatment of Hypertension and Heart Failure - An Update

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Tolerability, Safety, and Hemodynamics of Sacubitril-Valsartan in Acutely Decompensated Heart Failure Patients With Cardiogenic Shock

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy